Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset

Monetization of legacy asset brings in $3 million in nondilutive capital Convertible notes exchange brings in another$2.8 million in new capital and reduces Biora's net debt SAN DIEGO, March 11, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today announced an agreement with institutional investor Context Capital to invest $2.8 million in new capital alongside a convertible note exchange, and announced the monetization of its ...